Collegium Pharmaceutical, Inc. (COLL) Social Stream
Collegium Pharmaceutical Inc (COLL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Collegium Pharmaceutical Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 171 days, COLL's average price target has gone down $8.03.
COLL reports an average of 27.27% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
COLL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 31 weeks, COLL's average broker recommendation rating worsened by 0.07.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- COLL has a lower variance in analysts' estimates than -187.54% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Collegium Pharmaceutical Inc's number of analysts covering the stock is higher than 266.07% of them.
- In terms of how Collegium Pharmaceutical Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 44.33% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Collegium Pharmaceutical Inc's average analyst price target is greater than 121.42% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Collegium Pharmaceutical Inc are COGT, CNTB, and CNTA.
Is COLL a Buy, Hold or Sell? See the POWR Ratings now!